Erdheim-Chester disease: Report of a case with PCR-based analysis of the expression of osteopontin and survivin in xanthogranulomas following gluco corticoid treatment

Endocrine Journal

Volumn 55, Issue 1, 2008, Pages 217-223

  Taguchi, Takafumi ^a   Iwasaki, Yasumasa ^a   Asaba, Koichi ^a   Yoshida, Toshinori ^a   Takao, Toshihiro ^a   Ikeno, Fuminori ^a   Nakajima, Hideaki ^a   Kodama, Hajime ^a   Hashimoto, Kozo ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Diabetes insipidus; Erdheim Chester disease; Non langerhans histiocytosis; Osteopontin; Survivin; Xanthogranuloma

Indexed keywords

INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; METHYLPREDNISOLONE; OSTEOPONTIN; PREDNISOLONE; SURVIVIN; TUMOR MARKER; BIRC5 PROTEIN, HUMAN; GLUCOCORTICOID; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AXILLA; BONE PAIN; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES INSIPIDUS; DISEASE ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG PULSE THERAPY; ERDHEIM CHESTER DISEASE; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAMMARY GLAND; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PYREXIA IDIOPATHICA; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR REGRESSION; XANTHOGRANULOMA; FOLLOW UP; GENE EXPRESSION; GENETICS; GRANULOMA; XANTHOMATOSIS;

ADULT; ERDHEIM-CHESTER DISEASE; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GLUCOCORTICOIDS; GRANULOMA; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; OSTEOPONTIN; POLYMERASE CHAIN REACTION; PREDNISOLONE; XANTHOMATOSIS;

EID: 42049112157     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-044     Document Type: Article

References (30)

1. Chetritt J, Paradis V, Dargere D, et al. (1999) Chester-Erdheim disease: a neoplastic disorder. Hum Pathol 30: 1093-1096.
2. Braiteh F, Boxrud C, Esmaeli B, et al. (2005) Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. Blood 106: 2992-2994.
3. Weidauer S, von Stuckrad-Barre S, Dettmann E, et al. (2003) Cerebral Erdheim-Chester disease: case report and review of the literature. Neuroradiology 45: 241-245.
4. Gauvrit JY, Oppenheim C, Girot M, et al. (2004) Images in cardiovascular medicine. High resolution images obtained with ultrasound and magnetic resonance imaging of pericarotid fibrosis in Erdheim-Chester disease. Circulation 110: 443-444.
5. Egan AJ, Boardman LA, Tazelaar HD, et al. (1999) Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 23: 17-26.
6. Tritos NA, Weinrib S, Kaye TB. (1998) Endocrine manifestations of Erdheim-Chester disease (a distinct form of histiocytosis). J Intern Med 244: 529-535.
7. Franzius C, Sciuk J, Bremer C, et al. (1999) Determination of extent and activity with radionuclide imaging in Erdheim-Chester disease. Clin Nucl Med 24: 252-255.
8. Shields JA, Karcioglu ZA, Shields CL, et al. (1991) Orbital and eyelid involvement with Erdheim-Chester disease. A report of two cases. Arch Ophthalmol 109: 850-854.
9. Stojkovic T, de Seze J, Maurage CA, et al. (2000) Atypical form of non-Langerhans histiocytosis with disseminated brain and leptomeningeal lesions. J Neurol Neurosurg Psychiatry 69: 675-678.
10. Bourke SC, Nicholson AG, Gibson GJ (2003) Erdheim-Chester disease: pulmonary infiltration responding to cyclophosphamide and prednisolone. Thorax 58: 1004-1005.
11. Joo CU, Go YS, Kim IH, et al. (2005) Erdheim-Chester disease in a child with MR imaging showing regression of marrow changes. Skeletal Radiol 34: 299-302.
12. O'Regan A, Berman JS (2000) Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 81: 373-390.
13. Li F, Ambrosini G, Chu EY, et al. (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584.
14. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921.
15. Schneider S, Yochim J, Brabender J, et al. (2004) Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer. Clin Cancer Res 10: 1588-1596.
16. Tajiri T, Tanaka S, Shono K, et al. (2001) Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma. Cancer Lett 166: 89-94.
17. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. (1996) Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 75: 157-169.
18. Vencio EF, Jenkins RB, Schiller JL, et al. (2007) Clonal cytogenetic abnormalities in Erdheim-Chester disease. Am J Surg Pathol 31: 319-321.
19. Gotthardt M, Welcke U, Brandt D, et al. (2000) The role of bone scintigraphy in patients with Erdheim-Chester disease. Clin Nucl Med 25: 414-420.
20. Sedivy R, Peters K, Kloppel G (2005) Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas. Virchows Arch 446: 41-45.
21. Sakuma T, Higashibata Y, Kawahata H, et al. (2003) Difference of osteopontin gene regulation between bone and kidney. J Orthop Sci 8: 361-366.
22. Okada H, Moriwaki K, Kalluri R, et al. (2000) Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats. Am J Physiol Renal Physiol 278: F110-121.
23. Golledge J, McCann M, Mangan S, et al. (2004) Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke 35: 1636-1641.
24. Chen J, Singh K, Mukherjee BB, et al. (1993) Developmental expression of osteopontin (OPN) mRNA in rat tissues: evidence for a role for OPN in bone formation and resorption. Matrix 13: 113-123.
25. Ehrchen J, Heuer H, Sigmund R, et al. (2001) Expression and regulation of osteopontin and connective tissue growth factor transcripts in rat anterior pituitary. J Endocrinol 169: 87-96.
26. Oates AJ, Barraclough R, Rudland PS (1996) The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13: 97-104.
27. Takahashi F, Takahashi K, Shimizu K, et al. (2004) Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome. Lung 182: 173-185.
28. Matsuura F, Yamashita S, Hirano K, et al. (1999) Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia - a possible pathogenesis of necrobiotic xanthogranuloma. Atherosclerosis 142: 355-365.
29. Guarino V, Faviana P, Salvatore G, et al. (2005) Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. J Clin Endocrinol Metab 90: 5270-5278.
30. Bohlega S, Alwatban J, Tulbah A, et al. (1997) Cerebral manifestation of Erdheim-Chester disease: clinical and radiologic findings. Neurology 49: 1702-1705.